Audentes Therapeutics, Inc. (NASDAQ:BOLD) Files An 8-K Submission of Matters to a Vote of Security Holders

1.

Election of three Class I directors, Jonathan
Silverstein, Thomas Schuetz and Thomas Woiwode, each to
serve three-year terms through the third annual meeting
of stockholders following the 2017 annual meeting and
until a successor has been elected and qualified or until
earlier resignation or removal:

Nominees

Shares For

Shares Withheld

Broker Non-Votes

Jonathan Silverstein

15,278,911

1,950,254

461,302

Thomas Schuetz

15,886,760

1,342,405

461,302

Thomas Woiwode

15,886,060

1,343,105

461,302

2.

Ratification of the appointment of KPMG LLP as the
Companys independent registered public accounting firm
for the fiscal year ending December 31, 2017:

Shares For

Shares Against

Shares Abstaining

Broker Non-Votes

17,688,871

1,396